Although surgical portal flow diversion was initially achieved by Nicolai Eck in 1877, Pavlov was the first to describe the physiologic consequences of the portaprival state1. In 1893, Pavlov's careful observations of dogs with portacaval shunts resulted in the description of the syndrome of "meat intoxication" or portasystemic encephalopathy. In addition, autopsy studies disclosed that animals that developed portasystemic encephalopathy had patent portacaval shunts and atrophic livers, whereas dogs with thrombosed or stenosed shunts had normal livers and hepatopetal portal collaterals. Pavlov concluded from these experiments that portal blood flow was essential for maintenance of liver function and structure and that complete portal diversion caused psychoneurologic dysfunction secondary to hepatic functional deterioration from reduced nutrient liver blood flow and to intestinally absorbed cerebral toxins bypassing hepatic detoxification.
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Because A key factor in determining long-term maintenance of portal flow to the liver after the DSRS is etiology of liver disease. Patients with non-alcoholic cirrhosis and non-cirrhotic portal hypertension are more likely than patients with alcoholic cirrhosis to maintain hepatopetal portal flow in the late postoperative period39. Long-term follow-up of patients in the Emory randomized trial of DSRS versus nonselective shunt has shown that continuing portal flow to the liver was maintained for as long as 10 years in some patients with non-alcoholic cirrhosis4. In one series, 80% of non-alcoholic cirrhotics and only 25% of alcoholic cirrhotics had evidence of continuing portal perfusion of the liver at the one year evaluation39. The exact cause of this difference in post-shunt hemodynamic status between alcoholic and non-alcoholic cirrhosis is not clear. The group of patients most likely to maintain continuing hepatic portal perfusion after the DSRS are those with portal hypertension secondary to portal vein thrombosis 41 and to schistosomiasis, 42 but with normal liver architecture and function. Portal flow in patients with portal vein thrombosis is restored through hepatopetal collaterals, and since hepatic vascular resistance is normal, hepatic portal perfusion can usually be maintained indefinitely after the DSRS.
Other than the cause of portal hypertension, the extent to which the superior mesenteric venous part of the portal venous system is separated from the decompressed gastrosplenic component is another important factor in determining portal flow preservation. When the devascularization component of the operation is omitted, loss of portal flow through the coronary vein to the shunt is quite rapid43. However, even when portal-azygous disconnection is performed appropriately, portal flow is lost at a more rapid rate than in unshunted patients4'5.
Recently (Table 2 ). In six of these studies, the patient populations of both groups were comprised of predominantly patients with alcoholic cirrhosis and the seventh trial contrasted the DSRS to a nonselective shunt and a nonshunting procedure in schistosomiasis patients. To date, no investigation has compared different shunt procedures in patients with non-alcoholic cirrhosis. A consistent finding in all of the studies is that survival was not improved after the DSRS.
Four of the seven trials 4'69'71'73 have shown a significantly lower frequency of postshunt encephalopathy in the DSRS patients; however, the other three trials have demonstrated no significant difference between selective and nonselective shunts in the incidence of this complication. In contrast to survival, encephalopathy is a subjective endpoint which was assessed with a variety of methods in the different trials. One of the more objective assessments quantified encephalopathy by the number of postoperative hospital admissions required for the treatment of this complication. This trial showed significantly fewer days of hospitalization for encephalopathy in the DSRS than in the portacaval shunt group71. These discrepancies in the frequencies of post-DSRS encephalopathy are probably due to differences in the patient populations studied, the methods used in assessing neuropsychological function and surgical technique. It is possible that technical variations resulting in less complete portal-azygous disconnection in the DSRS groups of two trials contributed to the higher incidence of post-DSRS encephalopathy observed in these studies72'74.
Another important endpoint in comparing treatment for variceal hemorrhage is the effectiveness with which recurrent bleeding is prevented. Bleeding control was similar after selective and nonselective shunts in six of these studies 4'69-7'73'74 Likewise, selective and nonselective shunt occlusion rates were similar in these six trials. The Los Angeles study 72 showed a higher shunt failure rate after selective variceal decompression. The 30% incidence of recurrent variceal hemorrhage after the DSRS in that trial is the highest ever reported, suggesting a degree of surgeon inexperience with this procedure, as the frequency of DSRS failure was less than 10% for the other six studies combined.
In summary, these prospective randomized trials have shown no significant improvement in survival in alcoholic cirrhotic patients managed by the DSRS compared to those undergoing a nonselective shunt procedure. Selective variceal decompression provided a better quality of survival in four of the studies, even though three of these investigations contained mostly patients with alcoholic cirrhosis75. Prevention of recurrent variceal hemorrhage was equivalent for selective and nonselective shunts in six of the investigations. Although there are less controlled data, superiority of the DSRS may be more evident in patients with noncirrhotic portal hypertension 68'73 and in those with non-alcoholic cirrhosis32'65. A single controlled trial in patients with schistosomiasis showed a lower frequency of encephalopathy after DSRS than following a conventional splenorenal shunt. The morality rate was low after both procedures in this investigation. Two of these studies evaluated the effect of the DSRS and endoscopic sclerotherapy on hepatic hemodynamics and quantitative liver function44'45. Significantly more patients had continuing hepatic portal perfusion at the one-year assessment in the sclerotherapy groups of both of these investigations. This difference in portal flow between treatment groups resulted in significantly better hepatic functional reserve in the sclerotherapy group of the Atlanta study but not in the Omaha trial.
Our conclusion from these four studies is that chronic sclerotherapy is an acceptable, but not superior, alternative to the DSRS for management of patients with variceal hemorrhage. Recurrent variceal hemorrhage is common after definitive sclerotherapy and this treatment modality will fail in approximately one-third of patients. Although sclerotherapy may be the preferred initial treatment for many variceal bleeders, patients living in remote areas or those who are non-compliant with respect to their sclerotherapy schedule should probably undergo an initial shunt operation rather than receive chronic sclerotherapy. 
